Clinical Research and Evidence Generation

We equip clients with the knowledge to make informed, impactful decisions.

We support life sciences and health technology companies in generating robust evidence to inform product development, regulatory strategy, market access, and healthcare decision-making.
Evidence generation today must address not only clinical and regulatory requirements, but also the expectations of payers, providers, and health systems. We help clients define evidence priorities, select appropriate study approaches, and build integrated evidence strategies that support value demonstration across the product lifecycle.
Our work includes clinical and outcomes research, real-world evidence planning, patient-reported outcomes, evidence synthesis, and studies designed to support reimbursement, HTA, and market access decisions.
  • Market research and feasibility studies
  • Competitive landscape and patient journey mapping
  • Provider, payer, patient insights
  • Commercialization and launch strategy
  • Value proposition development for products and solutions

    1

    Other Services

    Regulatory Strategy and Market Access

    We help clients navigate regulatory pathways and secure access for:

    • Pharmaceuticals
    • Medical devices
    • In vitro diagnostics
    • Digital health technologies

    Our services include:

    1. Regulatory strategy, dossier preparation, submission
    2. Local adaptation of global registration files
    3. Fast-track, orphan, and early access pathways
    4. Health authority engagement and negotiation
    5. Pricing strategy, cost-effectiveness, budget impact modeling
    6. Reimbursement submissions and negotiation support
    7. Value-based healthcare (VBHC) contracting and outcome-based payment models
    Market Research, Strategy, and Commercial Planning

    We equip clients with the knowledge to make informed, impactful decisions.

    • Market research and feasibility studies
    • Competitive landscape and patient journey mapping
    • Provider, payer, patient insights
    • Commercialization and launch strategy
    • Value proposition development for products and solutions
    Medical Affairs and Stakeholder Engagement

    We help companies build scientific leadership, credibility, and trust.

    • KOL (Key Opinion Leader) identification and engagement
    • Advisory boards, expert panels, and scientific boards
    • Medical writing (protocols, publications, presentations)
    • Scientific communication strategy and materials
    • Medical affairs strategy and training
    • Internal and external education programs
    Policy, Health System, and VBHC Project Support

    We help clients and governments improve healthcare policy, financing, and delivery.

    • Evidence generation to inform clinical guidelines, reimbursement, and policy
    • Methodological support for national guideline development
    • White papers, policy briefs, and technical reports
    • Healthcare financing and payment reform
    • Public health program evaluation and optimization
    • Digital health evaluation, integration, and scale-up
    • VBHC project design, pilot development, and management with payers, providers, and governments
    Special Focus: Pharmaceutical and Medtech Clients

    For pharma, biotech, medtech, diagnostics, and digital health companies, we offer an integrated pathway:

    Clinical development → Market research → Commercial strategy → Regulatory approval → Pricing, HEOR, market access → Policy engagement → VBHC project management → Education, training, and stakeholder support.

    We also help our clients shape the broader healthcare environment — supporting guideline development, payment model design, public health programs, and national health priorities.